Novel cyclic templates of α-MSH give highly selective and potent antagonists/agonists for human melanocortin-3/4 receptors

Malcolm J. Kavarana, Der Trivedi, Minying Cai, Jinfa Ying, Matthew Hammer, Christopher Cabello, Paolo Grieco, Guoxia Han, Victor J Hruby

Research output: Contribution to journalArticle

45 Citations (Scopus)

Abstract

In an effort to develop highly selective and potent agonists and/or antagonists for the hMC3 and hMC4 receptors, a new approach involving the use of linker arms and a backbone to side chain cyclization strategy was employed. Three key analogues were identified to have the required selectivity and potency at the hMC3 or hMC4 receptors, implicated to play pivotal roles in energy homeostasis and other biological effects. The novel cyclic peptide (O)C-CH2-CH2-C(O)-c-[His6-D- Phe7-Arg8-Trp9-Lys10] -NH2 (1) was found to be a highly selective and potent agonist of the hMC4 receptor. Structure-activity studies have shown that replacing the succinyl linker arm of 1 by an o-phthalic acid group and substituting a D-Nal(2′)7 residue in place of D-Phe7 results in a potent antagonist 7 at the hMC4 receptor. Furthermore, increasing the 23-membered lactam ring of 1 by one carbon atom (succinyl → glutaric acid linker) gives a highly selective and potent antagonist 9 for the hMC3 receptor. Analogues 1, 7, and 9 therefore represent the first examples of a class of cyclic melanotropin ligands with high selectivity and defined biological activities at the physiologically important hMC3 and hMC4 receptors.

Original languageEnglish (US)
Pages (from-to)2644-2650
Number of pages7
JournalJournal of Medicinal Chemistry
Volume45
Issue number12
DOIs
StatePublished - Jun 6 2002

Fingerprint

Melanocortins
Melanocyte-Stimulating Hormones
Lactams
Cyclic Peptides
Cyclization
Bioactivity
Homeostasis
Carbon
Ligands
Atoms
glutaric acid
phthalic acid
polypeptide C
human MC3R protein
human MC4R protein

ASJC Scopus subject areas

  • Organic Chemistry

Cite this

Novel cyclic templates of α-MSH give highly selective and potent antagonists/agonists for human melanocortin-3/4 receptors. / Kavarana, Malcolm J.; Trivedi, Der; Cai, Minying; Ying, Jinfa; Hammer, Matthew; Cabello, Christopher; Grieco, Paolo; Han, Guoxia; Hruby, Victor J.

In: Journal of Medicinal Chemistry, Vol. 45, No. 12, 06.06.2002, p. 2644-2650.

Research output: Contribution to journalArticle

Kavarana, Malcolm J. ; Trivedi, Der ; Cai, Minying ; Ying, Jinfa ; Hammer, Matthew ; Cabello, Christopher ; Grieco, Paolo ; Han, Guoxia ; Hruby, Victor J. / Novel cyclic templates of α-MSH give highly selective and potent antagonists/agonists for human melanocortin-3/4 receptors. In: Journal of Medicinal Chemistry. 2002 ; Vol. 45, No. 12. pp. 2644-2650.
@article{efffdc3c7f6e421787abbe70b0c25d26,
title = "Novel cyclic templates of α-MSH give highly selective and potent antagonists/agonists for human melanocortin-3/4 receptors",
abstract = "In an effort to develop highly selective and potent agonists and/or antagonists for the hMC3 and hMC4 receptors, a new approach involving the use of linker arms and a backbone to side chain cyclization strategy was employed. Three key analogues were identified to have the required selectivity and potency at the hMC3 or hMC4 receptors, implicated to play pivotal roles in energy homeostasis and other biological effects. The novel cyclic peptide (O)C-CH2-CH2-C(O)-c-[His6-D- Phe7-Arg8-Trp9-Lys10] -NH2 (1) was found to be a highly selective and potent agonist of the hMC4 receptor. Structure-activity studies have shown that replacing the succinyl linker arm of 1 by an o-phthalic acid group and substituting a D-Nal(2′)7 residue in place of D-Phe7 results in a potent antagonist 7 at the hMC4 receptor. Furthermore, increasing the 23-membered lactam ring of 1 by one carbon atom (succinyl → glutaric acid linker) gives a highly selective and potent antagonist 9 for the hMC3 receptor. Analogues 1, 7, and 9 therefore represent the first examples of a class of cyclic melanotropin ligands with high selectivity and defined biological activities at the physiologically important hMC3 and hMC4 receptors.",
author = "Kavarana, {Malcolm J.} and Der Trivedi and Minying Cai and Jinfa Ying and Matthew Hammer and Christopher Cabello and Paolo Grieco and Guoxia Han and Hruby, {Victor J}",
year = "2002",
month = "6",
day = "6",
doi = "10.1021/jm020021z",
language = "English (US)",
volume = "45",
pages = "2644--2650",
journal = "Journal of Medicinal Chemistry",
issn = "0022-2623",
publisher = "American Chemical Society",
number = "12",

}

TY - JOUR

T1 - Novel cyclic templates of α-MSH give highly selective and potent antagonists/agonists for human melanocortin-3/4 receptors

AU - Kavarana, Malcolm J.

AU - Trivedi, Der

AU - Cai, Minying

AU - Ying, Jinfa

AU - Hammer, Matthew

AU - Cabello, Christopher

AU - Grieco, Paolo

AU - Han, Guoxia

AU - Hruby, Victor J

PY - 2002/6/6

Y1 - 2002/6/6

N2 - In an effort to develop highly selective and potent agonists and/or antagonists for the hMC3 and hMC4 receptors, a new approach involving the use of linker arms and a backbone to side chain cyclization strategy was employed. Three key analogues were identified to have the required selectivity and potency at the hMC3 or hMC4 receptors, implicated to play pivotal roles in energy homeostasis and other biological effects. The novel cyclic peptide (O)C-CH2-CH2-C(O)-c-[His6-D- Phe7-Arg8-Trp9-Lys10] -NH2 (1) was found to be a highly selective and potent agonist of the hMC4 receptor. Structure-activity studies have shown that replacing the succinyl linker arm of 1 by an o-phthalic acid group and substituting a D-Nal(2′)7 residue in place of D-Phe7 results in a potent antagonist 7 at the hMC4 receptor. Furthermore, increasing the 23-membered lactam ring of 1 by one carbon atom (succinyl → glutaric acid linker) gives a highly selective and potent antagonist 9 for the hMC3 receptor. Analogues 1, 7, and 9 therefore represent the first examples of a class of cyclic melanotropin ligands with high selectivity and defined biological activities at the physiologically important hMC3 and hMC4 receptors.

AB - In an effort to develop highly selective and potent agonists and/or antagonists for the hMC3 and hMC4 receptors, a new approach involving the use of linker arms and a backbone to side chain cyclization strategy was employed. Three key analogues were identified to have the required selectivity and potency at the hMC3 or hMC4 receptors, implicated to play pivotal roles in energy homeostasis and other biological effects. The novel cyclic peptide (O)C-CH2-CH2-C(O)-c-[His6-D- Phe7-Arg8-Trp9-Lys10] -NH2 (1) was found to be a highly selective and potent agonist of the hMC4 receptor. Structure-activity studies have shown that replacing the succinyl linker arm of 1 by an o-phthalic acid group and substituting a D-Nal(2′)7 residue in place of D-Phe7 results in a potent antagonist 7 at the hMC4 receptor. Furthermore, increasing the 23-membered lactam ring of 1 by one carbon atom (succinyl → glutaric acid linker) gives a highly selective and potent antagonist 9 for the hMC3 receptor. Analogues 1, 7, and 9 therefore represent the first examples of a class of cyclic melanotropin ligands with high selectivity and defined biological activities at the physiologically important hMC3 and hMC4 receptors.

UR - http://www.scopus.com/inward/record.url?scp=0037030692&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037030692&partnerID=8YFLogxK

U2 - 10.1021/jm020021z

DO - 10.1021/jm020021z

M3 - Article

VL - 45

SP - 2644

EP - 2650

JO - Journal of Medicinal Chemistry

JF - Journal of Medicinal Chemistry

SN - 0022-2623

IS - 12

ER -